• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体4基因多态性在前列腺增生易感性及预后中的预测作用。

The predictive role of toll-like receptor-4 genetic polymorphisms in susceptibility to and prognosis of prostatic hyperplasia.

作者信息

Qiu Yunhua, Zheng Jinzhou, Yang Jianfeng, Li Feng, Zhou Xiqiu, Song Xiaoyun

机构信息

Department of General Surgery, Pudong Branch of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P.R. China.

出版信息

Iran J Basic Med Sci. 2019 Jan;22(1):86-92. doi: 10.22038/ijbms.2018.33173.7922.

DOI:10.22038/ijbms.2018.33173.7922
PMID:30944713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6437452/
Abstract

OBJECTIVES

This study was aimed to evaluate whether single nucleotide polymorphisms (SNPs) of TLR4 and common living habits of prostate hyperplasia (BPH) patients would affect the subjects' risk and prognosis.

MATERIALS AND METHODS

We totally recruited 501 BPH patients and 964 healthy controls. The patients' international prostate symptom score (IPSS) and quality of life assessment (QoL) were designated as the prognostic indexes for BPH patients. Altogether 7 SNPs within TLR4 were selected, and the interactions among SNPs and living habits were explained with multi-factor dimensionality reduction (MDR) modeling.

RESULTS

The mutant alleles of rs10983755 (G>A) and rs1927907 (G>A) tended to put on risk of BPH, yet the wide alleles of rs4986791 (C>T) and rs115336889 (G>C) were associated with incremental susceptibility to BPH (<0.05). The rs10983755 (GA) and rs1927907 (GA) were suggested as the marker of non-aggressive BPH, whereas rs4986791 (TT) could symbolize aggressive BPH (<0.05). The homozygotes of rs4986791 (TT) and rs115336889 (CC) could improve the IPSS change, and rs115336889 (CC) was also correlated with more obviously ameliorated Qol change (<0.05). Finally, MDR modeling suggested that rs4986791 (TT) and rs115336889 (GG) shaped the genotyping combination featured by the lowest risk of BPH when smoking or drinking history was also evaluated.

CONCLUSION

The SNPs situated within TLR4 were potent candidates for predicting risk and prognosis of BPH patients, and their interactions within environmental parameters also helped to develop effective strategies for preventing and treating BPH.

摘要

目的

本研究旨在评估Toll样受体4(TLR4)的单核苷酸多态性(SNP)以及前列腺增生(BPH)患者的常见生活习惯是否会影响受试者的风险和预后。

材料与方法

我们共招募了501例BPH患者和964例健康对照者。将患者的国际前列腺症状评分(IPSS)和生活质量评估(QoL)指定为BPH患者的预后指标。共选择了TLR4基因内的7个SNP,并采用多因素降维(MDR)模型解释SNP与生活习惯之间的相互作用。

结果

rs10983755(G>A)和rs1927907(G>A)的突变等位基因倾向于增加BPH的风险,而rs4986791(C>T)和rs115336889(G>C)的野生型等位基因与BPH易感性增加相关(<0.05)。rs10983755(GA)和rs1927907(GA)被认为是非侵袭性BPH的标志物,而rs4986791(TT)可能代表侵袭性BPH(<0.05)。rs4986791(TT)和rs115336889(CC)的纯合子可改善IPSS变化,rs115336889(CC)也与更明显改善的QoL变化相关(<0.05)。最后,MDR模型表明,当同时评估吸烟或饮酒史时,rs4986791(TT)和rs115336889(GG)形成了BPH风险最低的基因分型组合。

结论

位于TLR4基因内的SNP是预测BPH患者风险和预后的有力候选指标,它们在环境参数中的相互作用也有助于制定有效的BPH防治策略。

相似文献

1
The predictive role of toll-like receptor-4 genetic polymorphisms in susceptibility to and prognosis of prostatic hyperplasia.Toll样受体4基因多态性在前列腺增生易感性及预后中的预测作用。
Iran J Basic Med Sci. 2019 Jan;22(1):86-92. doi: 10.22038/ijbms.2018.33173.7922.
2
Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.5p13.2和7q21.1区域的基因变异与α-肾上腺素能受体拮抗剂治疗良性前列腺增生有关。
Aging Male. 2017 Dec;20(4):250-256. doi: 10.1080/13685538.2017.1358261. Epub 2017 Aug 8.
3
Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.良性前列腺增生患者中SRD5A1和SRD5A2基因与代谢参数及特定激素水平的分子分析
Int J Environ Res Public Health. 2017 Oct 30;14(11):1318. doi: 10.3390/ijerph14111318.
4
Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.纤维母细胞生长因子受体基因在韩国良性前列腺增生中的作用。
Dis Markers. 2013;35(6):869-75. doi: 10.1155/2013/792941. Epub 2013 Dec 9.
5
Polymorphisms in toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population.中国汉族人群中,Toll 样受体 4 基因多态性与哮喘严重程度相关,但与易感性无关。
J Investig Allergol Clin Immunol. 2011;21(5):370-7.
6
Toll-like Receptor 4 Single-Nucleotide Polymorphisms and Heart Transplant Rejection.Toll样受体4单核苷酸多态性与心脏移植排斥反应
Transplant Proc. 2018 Sep;50(7):2110-2112. doi: 10.1016/j.transproceed.2018.04.001. Epub 2018 Apr 11.
7
Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology.热平衡疗法在老年良性前列腺增生男性中的应用:聚焦病因与病理生理学
Aging Male. 2017 Mar;20(1):28-32. doi: 10.1080/13685538.2016.1247151. Epub 2016 Dec 14.
8
Correlations of glucose metabolism, insulin resistance and inflammatory factors with symptom score of patients with benign prostatic hyperplasia.葡萄糖代谢、胰岛素抵抗和炎症因子与良性前列腺增生患者症状评分的相关性。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5077-5081. doi: 10.26355/eurrev_201808_15700.
9
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.度他雄胺联合坦索罗辛或单药治疗良性前列腺增生伴下尿路症状患者后国际前列腺症状评分变化的基线变量影响:CombAT 研究 4 年结果。
BJU Int. 2014 Apr;113(4):623-35. doi: 10.1111/bju.12500. Epub 2014 Jan 9.
10
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.基线参数对有症状的良性前列腺增生和前列腺肿大男性使用度他雄胺、坦索罗辛及联合治疗后国际前列腺症状评分变化的影响:CombAT研究的2年数据
Eur Urol. 2009 Feb;55(2):461-71. doi: 10.1016/j.eururo.2008.10.037. Epub 2008 Nov 6.

引用本文的文献

1
Inheritance patterns of lower urinary tract symptoms in adults: a systematic review.成人下尿路症状的遗传模式:一项系统综述。
BJU Int. 2025 Feb;135(2):192-203. doi: 10.1111/bju.16517. Epub 2024 Aug 26.

本文引用的文献

1
Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study.肥胖、糖尿病、血清葡萄糖与出生队列、种族/民族和性别相关的原发性肝癌风险:多相健康检查研究。
Cancer Epidemiol. 2016 Jun;42:140-6. doi: 10.1016/j.canep.2016.04.009. Epub 2016 May 2.
2
Type 2 diabetes and risk of hospital admission or death for chronic liver diseases.2 型糖尿病与慢性肝脏疾病住院或死亡风险。
J Hepatol. 2016 Jun;64(6):1358-64. doi: 10.1016/j.jhep.2016.01.014. Epub 2016 Jan 23.
3
Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network.
基于人工神经网络的 II 型糖尿病患者肝癌预测模型的开发。
Comput Methods Programs Biomed. 2016 Mar;125:58-65. doi: 10.1016/j.cmpb.2015.11.009. Epub 2015 Nov 27.
4
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.肝癌:与肥胖、脂肪肝和肝硬化的关联。
Annu Rev Med. 2016;67:103-17. doi: 10.1146/annurev-med-090514-013832. Epub 2015 Oct 14.
5
Outcomes of Total Laparoscopic Hysterectomy Using a 5-mm Versus 10-mm Laparoscope: A Randomized Control Trial.使用5毫米与10毫米腹腔镜进行全腹腔镜子宫切除术的结果:一项随机对照试验。
J Minim Invasive Gynecol. 2016 Jan;23(1):101-6. doi: 10.1016/j.jmig.2015.09.001. Epub 2015 Sep 11.
6
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.糖尿病可预测酒精性肝病和非酒精性脂肪性肝病患者发生肝硬化和肝细胞癌的风险。
J Clin Transl Hepatol. 2015 Mar;3(1):9-16. doi: 10.14218/JCTH.2015.00001. Epub 2015 Mar 15.
7
Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma.Toll样受体2、4和9在口腔舌鳞状细胞癌中的预测作用。
Oral Oncol. 2015 Jan;51(1):96-102. doi: 10.1016/j.oraloncology.2014.08.017. Epub 2014 Sep 26.
8
Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion?结核分枝杆菌与Toll样受体相互作用的结果:免疫反应还是免疫逃逸?
Immunol Cell Biol. 2014 Oct;92(9):741-6. doi: 10.1038/icb.2014.52. Epub 2014 Jul 1.
9
Measurement of serum PSA as a predictor of symptoms scored on the IPSS for patients with benign prostatic hyperplasia.
N Z Med J. 2014 Feb 14;127(1389):17-24.
10
The history of Toll-like receptors - redefining innate immunity.Toll 样受体的历史——重新定义固有免疫。
Nat Rev Immunol. 2013 Jun;13(6):453-60. doi: 10.1038/nri3446. Epub 2013 May 17.